Contents developed under contract GS35F386DA (08/30/2022) in which NIOSH retained all rights.

Per section 1.5 of the contract:
"As a part of this contract NIOSH will retain all rights to the developed materials, and any materials
derived from stock materials must be licensed for unlimited distribution within an executable."